RecruitingNCT06522347

Mycobacteria Registry Study: Prospective Observational Study in Austria


Sponsor

Ludwig Boltzmann Institute for Lung Health

Enrollment

1,000 participants

Start Date

Jan 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is: What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria? Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with non-tuberculous mycobacterial pneumonia and tuberculosis. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Klinik Hietzing

Vienna, Austria

Klinik Penzing

Vienna, Austria

Ludwig Boltzmann Institut for Lung Health

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06522347


Related Trials